Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

AVENUE THERAPEUTICS, INC. (ATXI) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

AVENUE THERAPEUTICS, INC. (ATXI), most recent 12 months reported: revenue $1.4M, net loss $2.78M. Latest balance sheet on file: liquid cash $1.94M. From SEC filings. Others in Pharmaceutical Preparations: CANNAPHARMARX, INC. · Ovid Therapeutics Inc. · LIPOCINE INC. · Cartesian Therapeutics, Inc. · Dare Bioscience, Inc. · LONGEVERON INC. · Neuphoria Therapeutics Inc. · China SXT Pharmaceuticals, Inc.

Stock screener

Watchlist